LXRX
Lexicon Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.24
−0.88%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+17.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 4, 2026 | DEBBANE RAYMOND · director | M-Exempt | 89,312 | $0.00 |
| Jun 4, 2026 | SOBECKI CHRISTOPHER J · director | M-Exempt | 89,312 | $0.00 |
| Jun 4, 2026 | Sullivan Diane E. · director | M-Exempt | 89,312 | $0.00 |
| Jun 4, 2026 | Swain Judith L · director | M-Exempt | 89,312 | $0.00 |
| Jun 4, 2026 | Amouyal Philippe · director | M-Exempt | 89,312 | $0.00 |
| Jun 4, 2026 | Cheung Ivan · director | M-Exempt | 89,312 | $0.00 |
| Jun 4, 2026 | BARKER SAM L · director | M-Exempt | 89,312 | $0.00 |
| May 8, 2026 | Artal Participations S.a r.l. · director, 10 percent owner: | M-Exempt | 408,435 | $0.00 |
| May 8, 2026 | Artal Participations S.a r.l. · director, 10 percent owner: | A-Award | 408,435 | $0.00 |
| May 8, 2026 | Artal Participations S.a r.l. · director, 10 percent owner: | M-Exempt | 20,421,735 | $0.00 |
| May 4, 2026 | BARKER SAM L · director | A-Award | 43,478 | $1.61 |
| May 4, 2026 | SOBECKI CHRISTOPHER J · director | A-Award | 43,478 | $1.61 |
| May 4, 2026 | Cheung Ivan · director | A-Award | 35,714 | $0.00 |
| May 4, 2026 | Cheung Ivan · director | A-Award | 43,478 | $1.61 |
| May 4, 2026 | Amouyal Philippe · director | A-Award | 35,714 | $0.00 |
| May 4, 2026 | Amouyal Philippe · director | A-Award | 43,478 | $1.61 |
| May 4, 2026 | DEBBANE RAYMOND · director | A-Award | 43,478 | $1.61 |
| May 4, 2026 | DEBBANE RAYMOND · director | A-Award | 35,714 | $0.00 |
| May 4, 2026 | Sullivan Diane E. · director | A-Award | 35,714 | $0.00 |
| May 4, 2026 | BARKER SAM L · director | A-Award | 35,714 | $0.00 |
| May 4, 2026 | SOBECKI CHRISTOPHER J · director | A-Award | 35,714 | $0.00 |
| May 4, 2026 | Swain Judith L · director | A-Award | 43,478 | $1.61 |
| May 4, 2026 | Sullivan Diane E. · director | A-Award | 43,478 | $1.61 |
| May 4, 2026 | Swain Judith L · director | A-Award | 35,714 | $0.00 |
| Feb 27, 2026 | DEBBANE RAYMOND · director | Purchase | 2,000 | $1.49 |
| Feb 25, 2026 | DEBBANE RAYMOND · director | Purchase | 100,000 | $1.47 |
| Feb 23, 2026 | DEBBANE RAYMOND · director | Purchase | 50,000 | $1.44 |
| Feb 23, 2026 | DEBBANE RAYMOND · director | Purchase | 100,000 | $1.48 |
| Feb 19, 2026 | Artal Participations S.a r.l. · director, 10 percent owner: | A-Award | 41,290 | $65 |
| Feb 18, 2026 | DEBBANE RAYMOND · director | Purchase | 76,857 | $1.31 |
Institutional positioning
13F filings over the trailing two quarters
New 77Increased 74Reduced 68Sold out 29
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Artal Group S.A. | Increased | 175,156,062 | Aug 13, 2026 |
| ARTAL GROUP S.A. | Increased | 154,734,327 | May 14, 2026 |
| FMR LLC | Increased | 51,782,045 | Aug 13, 2026 |
| FMR LLC | Increased | 45,056,338 | May 15, 2026 |
| SIREN, L.L.C. | Increased | 44,303,518 | May 14, 2026 |
| Siren, L.L.C. | Unchanged | 44,303,518 | Aug 13, 2026 |
| Sessa Capital IM, L.P. | Increased | 18,960,836 | Aug 14, 2026 |
| SESSA CAPITAL IM, L.P. | Increased | 17,912,961 | May 15, 2026 |
| BlackRock, Inc. | Increased | 17,348,741 | Aug 7, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 9,901,208 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 9,519,167 | May 15, 2026 |
| Point72 Asset Management, L.P. | Increased | 8,251,325 | Aug 14, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Increased | 7,814,606 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 6,244,372 | Aug 12, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 4,944,731 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 4, 2026